Travere Therapeutics, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/17/2026
Shares
4,278,180
Value ($000)
163,469
Weight
3.0%
2020 Q4 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).